Ensemble Orthopedics Gains FDA Clearance For PyroCarbon CMC Interpositional Implant

Ensemble CMC

Ensemble Orthopedics received FDA 510(k) clearance to market the Ensemble CMC Implant to treat early-stage osteoarthritis of the carpometacarpal (CMC) joint in a minimally invasive procedure.

Ensemble CMC is based on On-X® PyroCarbon, a proprietary form of pyrolytic carbon produced by On-X Life Technologies. The high strength, low modulus...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us